Envestnet Asset Management
SNDX icon

Envestnet Asset Management’s Syndax Pharmaceuticals SNDX Stock Holding History

Envestnet Asset Management’s Portfolio SNDX Stock Details SNDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$7.16M Buy
327,617
+285,745
+682% +$5.94M ﹤0.01% 2189
2026
Q1 		$978K Buy
41,872
+17,066
+69% +$371K ﹤0.01% 3480
2025
Q4 		$521K Buy
+24,806
New +$433K ﹤0.01% 3672

Other funds holding SNDX

Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
HWAM
Hennion & Walsh Asset Management Parsippany, New Jersey $3.5B AUM 41.95% 1-Year Est. Return
YIH
Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return
VIG
Vienna Insurance Group Warsaw, Poland $381M AUM 105.39% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
TIP
Torray Investment Partners Bethesda, Maryland $741M AUM 26.16% 1-Year Est. Return
HSA
Hussman Strategic Advisors Ellicott City, Maryland $434M AUM 19.64% 1-Year Est. Return
TE
Tema ETFs New York $3.09B AUM 72.72% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Envestnet Asset Management's SNDX Position: Q2 2026 in Review

Envestnet Asset Management increased its Syndax Pharmaceuticals (SNDX) stake by 682% in Q2 2026, buying an estimated $5.94M and bringing the position to 327,617 shares worth $7.16M. The position accounts for ﹤0.01% of the portfolio, ranked #2189.

Envestnet Asset Management first reported a position in SNDX in Q4 2025 and has held it in 3 quarters since. 48 funds tracked by Wall St. Rank hold SNDX as of Q2 2026.

  • Envestnet Asset Management held 327,617 shares of Syndax Pharmaceuticals worth $7.16M as of Q2 2026.
  • Envestnet Asset Management bought 285,745 Syndax Pharmaceuticals shares in Q2 2026, an estimated $5.94M.
  • Syndax Pharmaceuticals made up ﹤0.01% of Envestnet Asset Management's portfolio in Q2 2026, its #2189 holding.
  • Envestnet Asset Management first reported a position in Syndax Pharmaceuticals in Q4 2025 and has held it in 3 quarters since.
  • 48 funds tracked by Wall St. Rank held Syndax Pharmaceuticals as of Q2 2026.

Based on Envestnet Asset Management's 13F filing for Q2 2026, filed 3 Aug 2026.